Enveda Therapeutics
Clinical trials sponsored by Enveda Therapeutics, explained in plain language.
-
New asthma pill shows promise in early trial
Disease control Recruiting nowThis study tests an experimental pill called ENV-294 in 50 adults with moderate-to-severe asthma who already use inhalers. Participants take the pill or a placebo once daily for 12 weeks. Researchers will check if the drug is safe and helps control asthma symptoms and lung functi…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New pill could ease severe eczema – trial underway
Symptom relief Recruiting nowThis study tests whether a daily pill called ENV-294 can safely reduce eczema severity and itch in adults with moderate-to-severe atopic dermatitis. About 60 participants will take either the drug or a placebo for 12 weeks, with regular clinic visits and symptom diaries. The goal…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Symptom relief
Last updated May 26, 2026 03:57 UTC